FDA grants fast track designation to SHP-655 for hereditary thrombotic thrombocytopenic purpura March 23, 2017 No Comments
European Commission approves Cinryze to prevent and treat HAE attacks in children March 16, 2017 No Comments
BioCryst reports interim results from phase II Apex-1 trial of BCX-7353 in HAE Feb. 28, 2017 No Comments